SG317

SG317 is a chemically synthesized short hairpin RNA (sshRNA) designed to silence expression of prolyl hydroxylase domain protein 2 (PHD2) mRNA, thereby stabilizing hypoxia‑inducible factor (HIF) signaling to potentially enhance angiogenesis and tissue repair in ischemic or poorly perfused tissues. In preclinical work, SG317 was engineered as a rabbit‑specific sshRNA with a 19‑base pair blunt-ended stem and 2‑nucleotide loop that perfectly matches an analogous PHD2 mRNA site previously targeted in human cells, and was further optimized as SG317.m5 by introducing 2’‑O‑methyl modifications to improve stability without loss of potency.[5] It has been investigated experimentally in diabetic wound-healing models (including rabbit wounds treated via mesh dressings) as part of a therapeutic RNA platform but has not progressed to formal clinical development as a standalone drug.[5]